Global Periodontal Therapeutic Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Type;
Gingivitis, Chronic Periodontitis, Aggressive Periodontitis, and Necrotizing Periodontal.By Treatment;
Systematic Antibiotics - Doxycycline, Minocycline, Metronidazole & Local Antibiotics - Arestin, Chlorhexidine, and Others.By End User;
Dental Clinic, Hospitals, and Others.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).Introduction
Global Periodontal Therapeutic Market (USD Million), 2021 - 2031
In the year 2024, the Global Periodontal Therapeutic Market was valued at USD 623.21 million. The size of this market is expected to increase to USD 1,195.27 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 9.8%.
The Global Periodontal Therapeutic Market encompasses the vast landscape of treatments and products aimed at addressing periodontal diseases, which affect the gums and supporting structures of the teeth. This market is a crucial component of the broader dental care industry, driven by factors such as increasing awareness of oral health, a growing aging population susceptible to periodontal issues, and advancements in therapeutic techniques and products. From traditional treatments like scaling and root planing to innovative therapies such as laser treatments and regenerative techniques, the market offers a wide array of solutions tailored to various patient needs and preferences.
One of the primary drivers propelling the growth of the Global Periodontal Therapeutic Market is the rising prevalence of periodontal diseases worldwide. Factors such as poor oral hygiene, tobacco use, and genetic predispositions contribute to the increasing incidence of conditions like gingivitis and periodontitis, necessitating effective therapeutic interventions. Moreover, the market's expansion is fueled by ongoing research and development efforts aimed at introducing novel treatment modalities and improving existing ones, thereby enhancing patient outcomes and driving market growth.
Key players in the Global Periodontal Therapeutic Market include dental product manufacturers, pharmaceutical companies, and dental care providers, all contributing to the development, manufacturing, and distribution of periodontal treatments and therapies. Additionally, technological advancements, such as the integration of digital dentistry and the emergence of personalized medicine, are shaping the market landscape, offering new opportunities for growth and innovation. With an increasing focus on preventive oral care and the rising demand for minimally invasive treatment options, the Global Periodontal Therapeutic Market is poised for continued expansion in the years to come.
Global Periodontal Therapeutic Market Recent Developments
-
In September 2023, Bausch Health Companies Inc. and its oral health care division, OraPharma announced plans to team up with the League of United Latin American Citizens (LULAC), the biggest Hispanic group in the U.S. Their goal is to spread awareness about gum disease among Hispanic communities. This collaboration aims to help Hispanics better understand how to detect and treat gum disease.
-
In March 2023, Haleon initiated the BetterOralCareNation campaign in Malaysia to enhance oral health practices across the country. The campaign seeks to raise awareness about the importance of oral hygiene and promote better oral care habits among Malaysians.
Segment Analysis
The type segment of the market classifies periodontal therapies into various categories based on their purpose and approach. These include non-surgical treatments, such as scaling and root planing, which aim to remove plaque and tartar from below the gum line to prevent or manage periodontal disease. Surgical treatments, like flap surgery and bone grafting, are considered for more advanced cases where deep pockets or severe tissue damage exist. The classification also encompasses laser-assisted therapies, which offer a minimally invasive option for treating periodontal pockets and promoting tissue regeneration.
The treatment segment focuses on the specific procedures and therapeutic methods used to manage periodontal diseases. Treatments can range from preventive measures, such as professional cleaning and antimicrobial therapy, to advanced techniques, including regenerative procedures and soft tissue grafts. Treatments are tailored based on the severity of the condition, ranging from initial nonsurgical intervention for gingivitis to more intensive surgical and regenerative procedures for advanced periodontitis.
The end user segment provides insight into where periodontal therapies are most commonly administered. This includes dental clinics, hospitals, and specialized periodontal centers. Dental clinics are the primary settings for routine periodontal care and initial treatments, while hospitals may offer specialized periodontal services and treatments for complex cases that require multidisciplinary care. Specialized periodontal centers focus on advanced procedures and are equipped with specialized tools and technology to address severe periodontal conditions, contributing to the market’s growth.
The geography segment breaks down the market across different regions, revealing disparities in treatment availability and adoption. North America and Europe have established themselves as leaders due to advanced healthcare systems, high awareness levels, and well-developed dental care infrastructure. Asia-Pacific is showing robust growth due to increased awareness and access to healthcare, particularly in countries like China and India. Latin America and Middle East & Africa exhibit varied market conditions, with challenges in accessibility and affordability impacting growth. However, improvements in healthcare infrastructure and increasing investments are driving growth in these regions.
Global Periodontal Therapeutic Segment Analysis
In this report, the Global Periodontal Therapeutic Market has been segmented by Type, Treatment, End User and Geography.
Global Periodontal Therapeutic Market, Segmentation by Type
The Global Periodontal Therapeutic Market has been segmented by Type into Gingivitis, Chronic Periodontitis, Aggressive Periodontitis and Necrotizing Periodontal.
The segmentation of the Periodontal Therapeutic Market by type encompasses various forms of periodontal diseases, each requiring specific treatment approaches tailored to its severity and underlying causes. Gingivitis represents the mildest form of periodontal disease, characterized by inflammation of the gums caused primarily by plaque buildup. Treatment typically involves professional cleaning, improved oral hygiene practices, and regular dental check-ups to prevent progression to more severe forms of periodontal disease.Chronic periodontitis is the most common form of periodontal disease and is characterized by inflammation and gradual loss of the supporting bone structure around the teeth. Treatment may involve scaling and root planing to remove plaque and tartar, along with adjunctive therapies such as antibiotics or surgical interventions in advanced cases. Aggressive periodontitis, on the other hand, progresses rapidly and can lead to significant destruction of the gums and bone supporting the teeth, particularly in younger individuals. Treatment often requires aggressive interventions, including deep cleaning procedures, antibiotic therapy, and sometimes surgical procedures to halt disease progression and preserve oral health.
Necrotizing periodontal diseases are characterized by tissue necrosis, leading to rapid destruction of the gums and supporting structures of the teeth. Treatment typically involves intensive antimicrobial therapy, along with surgical debridement and supportive measures to manage pain and promote healing. Overall, the segmentation of the Periodontal Therapeutic Market by type highlights the diverse spectrum of periodontal diseases and underscores the importance of individualized treatment approaches tailored to the specific needs of each patient.
Global Periodontal Therapeutic Market, Segmentation by Treatment
The Global Periodontal Therapeutic Market has been segmented by Treatment into Systematic Antibiotics and Local Antibiotics.
The segmentation of the Periodontal Therapeutic Market by treatment into systematic antibiotics and local antibiotics reflects the diverse approaches employed in managing periodontal diseases. Systematic antibiotics are administered orally or intravenously and are designed to combat bacterial infections throughout the body, including those affecting the gums and supporting structures of the teeth. Common systematic antibiotics used in periodontal treatment include doxycycline, minocycline, and metronidazole, which work to reduce bacterial load and inflammation systemically.
In contrast, local antibiotics are directly applied to the affected gum tissue or pockets surrounding the teeth, delivering targeted therapy to the site of infection. Local antibiotics such as Arestin (minocycline) and chlorhexidine are often administered as gels, chips, or rinses and are designed to penetrate deep into periodontal pockets, where bacteria thrive. By delivering concentrated antimicrobial agents directly to the source of infection, local antibiotics offer a targeted and minimally invasive approach to periodontal therapy, reducing the need for systemic medications and enhancing treatment efficacy while minimizing side effects. This segmentation underscores the importance of tailoring treatment approaches to individual patient needs and the specific characteristics of their periodontal condition.
Global Periodontal Therapeutic Market, Segmentation by End User
The Global Periodontal Therapeutic Market has been segmented by End User into Dental Clinic, Hospitals and Others.
The segmentation of the Periodontal Therapeutic Market by end user reflects the diverse settings in which periodontal treatments are administered. Dental clinics serve as primary points of care for routine dental check-ups, cleanings, and basic periodontal treatments. These clinics are often the first line of defense in identifying and addressing periodontal issues, providing patients with essential preventive care and early intervention to maintain optimal oral health. Hospitals, on the other hand, cater to more complex cases of periodontal diseases requiring specialized treatments or surgeries.
They offer comprehensive care for patients with severe periodontal conditions, including those necessitating advanced surgical interventions or management of systemic complications. Additionally, the "Others" category may include specialized periodontal treatment centers, academic institutions, and community health centers that offer periodontal services outside the traditional clinic or hospital setting. This segmentation reflects the diverse landscape of healthcare providers involved in delivering periodontal therapies and underscores the importance of catering to varying patient needs across different care settings.
Global Periodontal Therapeutic Market, Segmentation by Geography
In this report, the Global Periodontal Therapeutic Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Periodontal Therapeutic Market Share (%), by Geographical Region, 2024
The dominance of North America in the periodontal treatment market in 2021 can be attributed to several key factors. The region has witnessed a significant increase in scientific research and the adoption of novel technologies aimed at advancing periodontal treatment options. With nearly half of adults aged 30 years and older in the United States affected by periodontal disease, according to data from the Centers for Disease Control and Prevention (CDC), there's a pressing need for effective treatment solutions. Moreover, as the population ages, the prevalence of periodontal diseases continues to rise, further driving the demand for periodontal treatments in North America. These factors collectively contribute to the region's leading position in the global periodontal treatment market.
In contrast, the periodontal treatment market in the Asia Pacific region is poised for robust growth, characterized by a higher compound annual growth rate (CAGR) during the forecast period. The region is experiencing a surge in the prevalence of oral diseases, including periodontal diseases, particularly in Southeast Asia and the Western Pacific. The Journal of Public Health & Emergency highlights the significant burden of periodontal disease in these areas, with the Western Pacific region showing the largest increase in prevalence in recent years. Furthermore, increasing awareness about oral health, greater adoption of periodontal treatment options, and strong support from governing authorities contribute to making the Asia Pacific region an increasingly lucrative market for periodontal therapies. As these trends continue to unfold, the region is expected to play a prominent role in driving the growth and evolution of the global periodontal treatment market.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Periodontal Therapeutic Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunities Analysis
Drivers:
- Advancements in Dental Technology
- Increasing Awareness and Education
-
Aging Population - The global aging population presents a substantial driver for the periodontal therapeutic market, as older individuals are particularly prone to developing periodontal diseases. With advancing age, the immune system tends to weaken, making older adults more susceptible to infections and inflammatory conditions, including those affecting the gums and supporting structures of the teeth. Additionally, the cumulative effects of decades of oral hygiene practices, combined with age-related changes in saliva composition and gum tissue integrity, contribute to an increased risk of periodontal issues among the elderly population.
Moreover, the prevalence of age-related conditions, such as diabetes and osteoporosis, further exacerbates the susceptibility to periodontal diseases in older adults. These comorbidities can compromise oral health and hinder the body's ability to combat gum infections, necessitating comprehensive periodontal treatments to prevent disease progression and maintain oral function. As the global population continues to age, the demand for effective periodontal therapies is expected to rise significantly, driving market growth and prompting innovation in treatment modalities tailored to the unique needs of elderly patients. By addressing the specific challenges associated with aging and periodontal health, the periodontal therapeutic market plays a vital role in promoting oral well-being and quality of life among older populations worldwide.
Restraints:
- Limited Access to Dental Care
- Regulatory Challenges
-
Preference for Non-Invasive Alternatives - The preference for non-invasive or alternative treatment options among some patients reflects a growing trend towards holistic approaches to healthcare and a desire to minimize reliance on conventional medical interventions. Natural remedies, such as herbal mouthwashes, essential oils, and herbal supplements, are sought after by individuals seeking gentler, more natural alternatives to traditional periodontal therapies. Likewise, lifestyle modifications, including dietary changes, stress reduction techniques, and smoking cessation programs, are increasingly recognized for their potential to positively impact periodontal health by addressing underlying factors contributing to gum disease.
Furthermore, over-the-counter oral care products, such as antimicrobial mouthwashes, herbal toothpaste, and oral irrigators, offer consumers a convenient and accessible means of managing periodontal conditions at home. While these products may not provide the same level of efficacy as professional treatments, they appeal to individuals seeking cost-effective and non-invasive solutions for maintaining oral hygiene and preventing gum disease progression. The growing demand for non-conventional periodontal therapies underscores the importance of offering a diverse range of treatment options that cater to varying patient preferences and priorities within the Global Periodontal Therapeutic Market. As healthcare providers and manufacturers strive to meet the evolving needs of patients, there exists an opportunity to integrate complementary approaches into traditional periodontal care delivery models, ultimately enhancing patient satisfaction and driving market growth.
Opportunities:
- Personalized Medicine Approaches
- Expansion in Emerging Markets
-
Integration of Digital Health Solutions - The integration of digital health solutions into periodontal care delivery represents a paradigm shift in how dental professionals engage with patients and manage their oral health. Telemedicine platforms enable individuals to consult with periodontists remotely, breaking down geographical barriers and providing access to specialized care regardless of location. Through video consultations and virtual appointments, patients can receive timely advice, discuss treatment options, and address concerns without the need for in-person visits, thereby increasing convenience and accessibility.
Moreover, digital platforms empower patients to take a more proactive role in managing their periodontal health. With access to electronic health records and remote monitoring tools, individuals can track their progress, monitor key metrics such as gum health and inflammation levels, and adhere to personalized treatment plans more effectively. This real-time feedback loop fosters greater engagement and accountability, leading to improved treatment outcomes and long-term oral health benefits. Additionally, digital health solutions streamline administrative tasks, such as appointment scheduling and prescription management, freeing up valuable time for dental professionals to focus on delivering high-quality care and further enhancing the patient experience. As the healthcare landscape continues to embrace digital transformation, the integration of these technologies into periodontal care delivery will play an increasingly pivotal role in shaping the future of oral healthcare.
Competitive Landscape Analysis
Key players in Global Periodontal Therapeutic Market include
- Fibrocell Sciences, Inc
- Tolmar Inc
- Eli Lilly & Company
- Align Technology Inc.
- Dentsply International
- 3M-ESPE
- Ultradent Products Inc
- Glidewell Laboratories, Inc
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Treatment
- Market Snapshot, By End User
- Market Snapshot, By Region
- Global Periodontal Therapeutic Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Advancements in Dental Technology
- Increasing Awareness and Education
- Aging Population
- Restraints
- Limited Access to Dental Care
- Regulatory Challenges
- Preference for Non-Invasive Alternatives
- Opportunities
- Personalized Medicine Approaches
- Expansion in Emerging Markets
- Integration of Digital Health Solutions
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Periodontal Therapeutic Market, By Type, 2021 - 2031 (USD Million)
- Gingivitis
- Chronic Periodontitis
- Aggressive Periodontitis
- Necrotizing Periodontal
- Global Periodontal Therapeutic Market, By Treatment, 2021 - 2031 (USD Million)
- Systematic Antibiotics
- Doxycycline
- Minocycline
- Metronidazole & Local Antibiotics
- Arestin
- Chlorhexidine
- Others
- Systematic Antibiotics
- Global Periodontal Therapeutic Market, By End User, 2021 - 2031 (USD Million)
- Dental Clinic
- Hospitals
- Others
- Global Periodontal Therapeutic Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Periodontal Therapeutic Market, By Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Fibrocell Sciences, Inc
- Tolmar Inc
- Eli Lilly & Company
- Align Technology Inc.
- Dentsply International
- 3M-ESPE
- Ultradent Products Inc
- Glidewell Laboratories, Inc
- Company Profiles
- Analyst Views
- Future Outlook of the Market